Home
News
About
Company profile
Company culture
Company honor
Orgaization
Branch
Company history
Company staff
Products
Gynecology
Respiratory system
Hormones
Antipyretic analgesic
Spiritual
Antiviral
Antibacterial
Oral anesthetics
Urology
Masks
Water-electrolyte balance
Digestive system
Cardiovascular
Pieces
Nutrition and Metabolism
API
Service
Service concept
Bid Information
Contact
用药常识
女性健康
感冒预防
高血压防治
疼痛防治
家庭保健
儿童健康
心脑血管
Enter the pharmaceutical retail field and extend to the end of the industrial chain
In June 2004, it invested in the acquisition of Anhui Fengyuan Group Co., Ltd., which held 72.6% of the equity of "Anhui Fengyuan Pharmacy Chain Co., Ltd.", entered the pharmaceutical retail field, and extended to the end of the industrial chain.
2021
08-06
Implement the distribution plan of "10 get 2 for 8 shares"
In December 2003, the distribution plan of "10 get 2 for 8 shares" was implemented, and the registered capital of the company after the transfer of shares was changed to RMB 130 million.
Changed its name to "Anhui Fengyuan Pharmaceutical Co., Ltd."
In February 2003, "Anhui Xinli Pharmaceutical Co., Ltd." was renamed "Anhui Fengyuan Pharmaceutical Co., Ltd.".
Production line project construction
In October 2002, the company started the construction of two plastic bottle infusion production lines and two soft bag infusion production lines.
The actual controller was changed to "Anhui Fengyuan Group Co., Ltd."
In July 2002, the actual controller of the company was changed to "Anhui Fengyuan Group Co., Ltd.".
Software and hardware transformation to improve quality management level
In January 2001, it was decided to start the software and hardware transformation of each production area to improve the quality management level.
Listed on Shenzhen Stock Exchange, stock abbreviation: Xinli Pharmaceutical (code 000153)
In November 1998, the capital increase was carried out
In November 1998, the company increased capital and shares, adding new shareholders: Anhui Bengbu Tushan Pharmaceutical Factory, Anhui Maanshan Biochemical Pharmaceutical Factory, and Anhui Pharmaceutical Research Institute.
"Anhui Xinli Pharmaceutical Co., Ltd." was established
In August 1997, Anhui Wuwei Pharmaceutical Factory, Anhui Chaohu Fengbao Pharmaceutical Factory, Anhui Wuwei County Tengfei Pharmaceutical Packaging Factory, Anhui Wuwei County Printing Factory and Wuwei County Economic and Trade Construction Engineering Company jointly initiated the establishment of "Anhui Xinli". Pharmaceutical Co., Ltd.".
如何防治乳腺增生病的发生
近年来，随着生存环境的变化，乳腺增生发病率上升很快，此症已成为城市女性主要杀手。一旦患乳腺增生症，除了疼痛、肿块外，患者在情绪上必有烦躁，易怒，恐惧等，生理上有功能下降，如性欲淡漠，月经紊乱，体力下降，尿频等，在病理上多伴有妇科病，子宫内膜异位症等。对此未能全身综合标本兼治，久治未果就有转为乳腺癌的危险。
86-0551-64846100
127841476@qq.com
CopyRight © 2022 Anhui BBCA Pharmaceuticals Co., Ltd Powered by：www.300.cn SEO
448022937@qq.com
+182619958320
+0551-64846105